Batu Biologics Releases Shareholder Letter

Company discusses the clinical progress of the ValloVax Therapeutic Vaccine at the CHIPSA Hospital

Samuel C. Wagner, President and CEO of Batu Biologics, has issued the following letter to the shareholders of the Company, providing a comprehensive update on the clinical progress of the ValloVax immune therapy:

Read the full article at businesswire.com